News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lundbeck Inc. to Begin China Co-Promotion of Lexapro(R)


12/16/2010 11:03:27 AM

December 16, 2010 -- In a move to increase its China revenues, H. Lundbeck A/S of Denmark will begin co-promoting Lexapro®, its SSRI-class treatment for depression in the PRC. Previously, Xian-Janssen was exclusively in charge of China marketing for the drug, under an agreement signed in 2002. Both companies agreed to increase their investment in marketing to further increase sales. More details....

Read at BioSpace.com
Read at ChinaBio Today

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES